Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Nature Reviews. Immunology
|
February 6, 2019
Macrophages as regulators of tumour immunity and immunotherapy
David G DeNardo, Brian Ruffell
Trends in Pharmacological Sciences
|
November 7, 2024
Targeting dendritic cells to drive PDAC immunotherapy response
Alyssa G Weinstein, David G DeNardo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2023
Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough
Varintra E Lander, David G DeNardo
Breast Cancer Research : BCR
|
August 21, 2007
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G DeNardo, Lisa M Coussens
Cancer Discovery
|
August 3, 2019
A Single-Cell Window into Pancreas Cancer Fibroblast Heterogeneity
Jad I Belle, David G DeNardo
Immunity
|
April 19, 2018
Better Together: B7S1 Checkpoint Blockade Synergizes with anti-PD1
Melissa A Meyer, David G DeNardo
Breast Cancer Research : BCR
|
July 20, 2012
Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes
Jonathan B Mitchem, David G DeNardo
Cancer Immunology, Immunotherapy : CII
|
April 29, 2017
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Hong Jiang, Samarth Hegde, David G DeNardo
Cancer Metastasis Reviews
|
December 11, 2007
Immune cells as mediators of solid tumor metastasis
David G DeNardo, Magnus Johansson, Lisa M Coussens
Cancer Discovery
|
February 8, 2024
"RIPping" off Pancreas Cancer's Blockage of Immune Surveillance
Xiuting Liu, Blake E Sells, David G DeNardo
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Nature Reviews. Immunology
|
February 6, 2019
Macrophages as regulators of tumour immunity and immunotherapy
David G DeNardo, Brian Ruffell
Trends in Pharmacological Sciences
|
November 7, 2024
Targeting dendritic cells to drive PDAC immunotherapy response
Alyssa G Weinstein, David G DeNardo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2023
Pancreatic Cancer's PD1-Roadblock: When T-Cell Reinvigoration Is Not Enough
Varintra E Lander, David G DeNardo
Breast Cancer Research : BCR
|
August 21, 2007
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
David G DeNardo, Lisa M Coussens
Cancer Discovery
|
August 3, 2019
A Single-Cell Window into Pancreas Cancer Fibroblast Heterogeneity
Jad I Belle, David G DeNardo
Immunity
|
April 19, 2018
Better Together: B7S1 Checkpoint Blockade Synergizes with anti-PD1
Melissa A Meyer, David G DeNardo
Breast Cancer Research : BCR
|
July 20, 2012
Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes
Jonathan B Mitchem, David G DeNardo
Cancer Immunology, Immunotherapy : CII
|
April 29, 2017
Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy
Hong Jiang, Samarth Hegde, David G DeNardo
Cancer Metastasis Reviews
|
December 11, 2007
Immune cells as mediators of solid tumor metastasis
David G DeNardo, Magnus Johansson, Lisa M Coussens
Cancer Discovery
|
February 8, 2024
"RIPping" off Pancreas Cancer's Blockage of Immune Surveillance
Xiuting Liu, Blake E Sells, David G DeNardo
Page
of 11